Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9248119
SERIAL NO

13160572

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICALS U S A INC500 KENDALL STREET CAMBRIDGE MA 02142

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gupte, Vijay Vernon Hills, US 5 7
Taneja, Rajneesh Libertyville, US 46 462
Vakilynejad, Majid Gurnee, US 5 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 2, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00